Christopher Roberts
Non-Executive Director / Clarity Pharmaceuticals
Dr Christopher Roberts AO is a highly experienced director and senior executive with 40 years of experience in the medical innovation space
He was chief executive of Cochlear from February 2004 to August 2015, chair of Sirtex Medical from March 2000 to December 2002, and executive vice president of global sleep disorder treatment company ResMed from 1992 to 2004.
Dr Roberts is a PLuS Alliance Professor appointed across 3 universities: UNSW, King’s College London and Arizona State University.
Dr Roberts also sits on the boards of several other entities and groups including Innovation Science Australia, Biomedical Translation Fund, Jobs for NSW, and the NHMRC’s Health Innovation Advisory Committee.
